Jeffrey Lightcap Purchases 40,000 Shares of Heartflow (NASDAQ:HTFL) Stock

Heartflow, Inc. (NASDAQ:HTFL) Director Jeffrey Lightcap bought 40,000 shares of Heartflow stock in a transaction on Tuesday, December 16th. The shares were purchased at an average cost of $26.34 per share, with a total value of $1,053,600.00. Following the acquisition, the director directly owned 40,000 shares of the company’s stock, valued at approximately $1,053,600. The trade was a ∞ increase in their ownership of the stock. The purchase was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through this link.

Heartflow Trading Up 9.0%

Shares of NASDAQ:HTFL opened at $28.65 on Friday. Heartflow, Inc. has a 1 year low of $25.38 and a 1 year high of $41.22. The stock has a 50 day moving average price of $31.98.

Heartflow (NASDAQ:HTFL) last announced its quarterly earnings data on Friday, September 19th. The company reported ($1.46) earnings per share for the quarter, missing analysts’ consensus estimates of ($0.20) by ($1.26). The business had revenue of $43.42 million during the quarter, compared to the consensus estimate of $43.20 million.

Wall Street Analysts Forecast Growth

HTFL has been the topic of several research reports. Zacks Research raised shares of Heartflow to a “hold” rating in a research note on Wednesday, September 3rd. Canaccord Genuity Group increased their price objective on shares of Heartflow from $39.00 to $40.00 and gave the company a “buy” rating in a report on Thursday, November 13th. JPMorgan Chase & Co. boosted their target price on Heartflow from $36.00 to $40.00 and gave the stock an “overweight” rating in a report on Thursday, November 13th. Weiss Ratings reaffirmed a “sell (d)” rating on shares of Heartflow in a report on Monday. Finally, Morgan Stanley initiated coverage on Heartflow in a research note on Tuesday, September 2nd. They set an “equal weight” rating and a $35.00 price objective on the stock. Four investment analysts have rated the stock with a Buy rating, two have issued a Hold rating and one has issued a Sell rating to the company’s stock. According to MarketBeat.com, Heartflow presently has a consensus rating of “Hold” and a consensus price target of $38.60.

Institutional Trading of Heartflow

Several hedge funds have recently made changes to their positions in HTFL. Wellington Management Group LLP purchased a new stake in shares of Heartflow during the 3rd quarter valued at approximately $164,263,000. Baillie Gifford & Co. purchased a new position in Heartflow in the third quarter worth approximately $101,182,000. Schusterman Interests LLC acquired a new stake in Heartflow during the third quarter worth $65,274,000. Vanguard Group Inc. purchased a new stake in Heartflow in the third quarter valued at $48,871,000. Finally, Capital International Investors acquired a new position in shares of Heartflow in the 3rd quarter valued at $43,671,000.

About Heartflow

We have pioneered the use of software and AI to deliver a more accurate and clinically effective non-invasive solution for diagnosing and managing coronary artery disease (“CAD”), a leading cause of death worldwide. As of March 31, 2025, our Heartflow Platform has been used to assess CAD in more than 400,000 patients, including 132,000 in 2024 alone.